‘The trajectory is encouraging.’ Roche hopes obesity drug will show 25% weight loss one day

Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.